SCHEMBL5214826

SCHEMBL5214826

CCOC(=O)c1c(S(=O)(=O)N2CCS(=O)(=O)CC2)c2ccccc2n1Cc1ccc(Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 10/20 0.48
HTT P42858 2/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
GAA P10253 1/20 0.47
ALDH1A1 P00352 4/20 0.43
NCOA1 Q15788 1/20 0.43
NCOA3 Q9Y6Q9 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
KDM4E B2RXH2 1/20 0.40
ABCB11 O95342 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NOD2 Q9HC29 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5214833 0.93 CCR2 (0.48) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5215970 0.90 CCR2 (0.50) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5220393 0.87 CCR2 (0.61) CCR2HTTLMNAMAPTALDH1A1
SCHEMBL5219665 0.84 CCR2 (0.56) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5214254 0.83 CCR2 (0.52) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5217434 0.81 CCR2 (0.48) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5216150 0.81 CCR2 (0.55) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5220401 0.80 CCR2 (0.61) CCR2LMNAMAPTALDH1A1CYP1A2
SCHEMBL5213680 0.78 CCR2 (0.65) CCR2HTTLMNAMAPTSMN1; SMN2
SCHEMBL5216641 0.78 MEN1 (0.63) CCR2HTTLMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173421-B1 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2007-10-03 EP disclosed
US-6833387-B1 3-substituted indoles; inhibition of monocyte chemoattractant protein-1 and/or RANTES induced chemotaxis; inflammatory diseases ASTRAZENECA AB (SE) 2004-12-21 US disclosed
EP-1173421-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS AstraZeneca AB (SE) 2002-01-23 EP disclosed
WO-2000046199-A2 INDOLE DERIVATIVES AS ANTI-INFLAMMATION AGENTS ASTRAZENECA AB (SE) 2000-08-10 WO disclosed